{"id":"W2033135115","doi":"10.1002/ibd.21521","title":"Efficacy and safety of certolizumab pegol in an unselected crohnʼs disease population","year":2010,"lang":"en","type":"article","venue":"Inflammatory Bowel Diseases","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":25,"is_retracted":false,"has_abstract":true,"ca_institutions":"McMaster University","funders":"Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; National Science Foundation","keywords":"Medicine; Certolizumab pegol; Adverse effect; Infliximab; Internal medicine; Adalimumab; Crohn's disease; Population; Inflammatory bowel disease; Maintenance therapy; Surgery; Pediatrics; Disease; Gastroenterology; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007774857,0.0003238123,0.0004225959,0.0004923391,0.0004983534,0.0005291712,0.0001608268,0.0004536629,0.001065654],"category_scores_gemma":[0.001594434,0.0001777751,0.0002789704,0.0003270968,0.0003653585,0.0003141144,0.0002723025,0.00037471,0.0002845578],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002863994,"about_ca_system_score_gemma":0.0002665523,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008309401,"about_ca_topic_score_gemma":0.0008613811,"domain_scores_codex":[0.9995435,0.000159449,0.00003853149,0.0001173776,0.00007948098,0.0000616854],"domain_scores_gemma":[0.9991786,0.0001776288,0.0003005265,0.00004402563,0.00007180166,0.0002273808],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.002016563,0.0006502268,0.9907995,0.00002268939,0.00005954791,0.0004789123,0.0002021369,0.00005554759,0.001321267,0.00001117238,0.0001266348,0.004255811],"study_design_scores_gemma":[0.0003360047,0.00568379,0.9911691,0.000007105591,0.0000716448,0.001662408,0.0002289544,0.0002437758,0.0002056778,0.00002398377,0.0003587144,0.000008817769],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9997166,0.00009865007,0.0000162861,0.00001633062,0.000001600049,0.00001005083,0.0000373127,0.000001065821,0.000102075],"genre_scores_gemma":[0.9996175,0.00006822254,0.00004227781,0.00005145295,0.00001403756,0.00001279468,0.0001251906,8.749994e-7,0.00006773728],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001065654,"threshold_uncertainty_score":0.004111767,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.005261069346568975,"score_gpt":0.2388348177821188,"score_spread":0.2335737484355498,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}